Gerber Scientific Announces Grant of License Under its 'Print to Cut' Patent

SOUTH WINDSOR, Conn., March 18 /PRNewswire-FirstCall/ -- Gerber Scientific, Inc. NYSE: GRB, a worldwide leader in integrated automation solutions, including the world's sign making and specialty graphics industries, announced today that it has granted a worldwide license to a major Japanese printer manufacturer. This is a non-exclusive license under the Company's family of patents based upon its pioneer U.S. Patent 5,537,135 [135 Patent] relating to computerized "print to cut" technology. Terms of the license are confidential.

"Given the market interest in being able to practice this technology, Gerber has agreed to permit other companies the opportunity to license these patents, further advancing the industry as a whole. Importantly, it also recognizes Gerber's commitment to maximize shareholder value through the licensing, and if need be, the enforcement of the Company's intellectual property rights," said Marc T. Giles, President and CEO of Gerber Scientific Inc.

The Company is presently prosecuting an action for infringement of the 135 Patent in the Federal District Court in Hartford, Connecticut against Roland DGA Corporation, the distribution and sales arm of Roland DG Corporation of Hamamatsu, Japan, in which the Company is seeking damages and an injunction against Roland's sale of infringing products. The lawsuit is currently in the discovery phase, pending the setting of a trial date.

About Gerber Scientific, Inc.

Gerber Scientific, Inc. (http://www.gerberscientific.com) is a leading international supplier of sophisticated automated manufacturing systems for sign making and specialty graphics, apparel and flexible materials, ophthalmic lens processing, and print and packaging industries. Headquartered in South Windsor, Connecticut, the company operates through four businesses: Gerber Scientific Products and Spandex Ltd., Gerber Technology, and Gerber Coburn.

Forward-looking Statements:

This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements contained in this news release regarding the Company's expected financial condition, results of operations, cash flows and product launches are forward-looking statements that involve risks and uncertainties. For information identifying other important economic, political, regulatory, legal, technological, competitive and other risks and uncertainties, readers are referred to the Company's filings with the Securities and Exchange Commission, including but not limited to, the information included in Gerber Scientific's Annual Report on Form 10-K for the fiscal year ended April 30, 2007 under the headings "Business," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations - Cautionary Note Concerning Factors That May Influence Future Results," as well as information included in subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K, which outline certain important risks regarding the Company's forward-looking statements. These risks include, but are not limited to, delays in the Company's new product development and commercialization, intense competition in markets for each of the Company's operating segments, rapid technological advances, availability and cost of raw materials, volatility in foreign currency exchange rates and fluctuations in interest rates. Actual future results or events may differ materially from those expressed or implied in the Company's forward-looking statements. The Company expressly disclaims any obligation to update any of these forward-looking statements.